PARP Inhibitors Revolutionising Cancer Treatment

Cells try to repair damaged DNA via a natural repair system called PARP — but cancers also take advantage of this repair system to thrive. This is the principle underlying the development of potential new therapies, including a next-generation PARP inhibitor that is designed to selectively maximise DNA damage to cancer cells. Our aim? To open up the possibility for powerful combination therapies– all for the benefit of patients.
Read more...

;